FIRST MANHATTAN CO. LLC. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2016$5,000
-28.6%
3,0000.0%0.00%
Q1 2016$7,000
-86.0%
3,000
-14.3%
0.00%
Q2 2014$50,000
+38.9%
3,5000.0%0.00%
Q1 2014$36,000
+44.0%
3,500
+40.0%
0.00%
Q4 2013$25,000
+177.8%
2,5000.0%0.00%
Q3 2013$9,0002,5000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders